Dallas Nephrology Associates

Dallas, Texas 75235-2208

1 studies enrolling now · 8 studies all time

What they study most

Arteriovenous Fistula Stenosis, Chronic Kidney Disease, Chronic Kidney Disease Requiring Chronic Dialysis, Chronic Kidney Diseases, End Stage Kidney Disease, End Stage Renal Disease, End Stage Renal Disease on Dialysis, Fabry Disease, Focal Segmental Glomerulosclerosis, Immunoglobulin A (IgA) Nephropathy, Kidney Diseases, Kidney Transplant

Studies at this site

• Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V — Recruiting now
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis — Running, not enrolling
• FLEX Vessel Prep Prior to Angioplasty in Native Arteriovenous Fistulae (AVF) — Completed
• Open-Label Expanded Access Treatment With Pegunigalsidase Alfa for Fabry Disease Patients — APPROVED_FOR_MARKETING
• Pathways Project: Kidney Supportive Care — Completed
• Dialysis Clinical Outcomes Revisited (DCOR) Trial — Completed
• Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) — Completed